Xylem Inc. (NYSE:XYL) Shares Sold by Impax Asset Management Group plc

Impax Asset Management Group plc lowered its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,975,817 shares of the industrial products company's stock after selling 57,109 shares during the quarter. Impax Asset Management Group plc owned approximately 0.82% of Xylem worth $225,954,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Panagora Asset Management Inc. increased its holdings in Xylem by 21.7% in the 1st quarter. Panagora Asset Management Inc. now owns 14,297 shares of the industrial products company's stock worth $1,219,000 after acquiring an additional 2,550 shares in the last quarter. Yousif Capital Management LLC lifted its position in Xylem by 1.5% in the first quarter. Yousif Capital Management LLC now owns 27,307 shares of the industrial products company's stock worth $2,328,000 after buying an additional 416 shares during the last quarter. Blair William & Co. IL increased its stake in Xylem by 0.5% in the first quarter. Blair William & Co. IL now owns 66,243 shares of the industrial products company's stock worth $5,648,000 after purchasing an additional 299 shares during the period. Sei Investments Co. increased its stake in Xylem by 6.7% in the first quarter. Sei Investments Co. now owns 335,330 shares of the industrial products company's stock worth $28,590,000 after purchasing an additional 21,165 shares during the period. Finally, Prudential PLC purchased a new stake in Xylem in the first quarter worth $333,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Insider Activity

In related news, SVP Franz Cerwinka sold 2,408 shares of the business's stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business's stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares of the company's stock, valued at $360,682.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Franz Cerwinka sold 2,408 shares of the business's stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Company insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on XYL. Raymond James upgraded Xylem from an "underperform" rating to a "market perform" rating in a research note on Thursday, January 4th. Robert W. Baird raised their price target on Xylem from $141.00 to $148.00 and gave the company an "outperform" rating in a research note on Thursday, March 21st. Royal Bank of Canada raised their price target on Xylem from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Wednesday, February 7th. BNP Paribas assumed coverage on Xylem in a research note on Tuesday, March 12th. They set an "outperform" rating and a $150.00 price target on the stock. Finally, Wolfe Research initiated coverage on Xylem in a research note on Wednesday, December 13th. They set an "outperform" rating and a $127.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $135.44.

Xylem Stock Performance

NYSE:XYL traded up $1.18 during trading hours on Tuesday, reaching $128.93. The company had a trading volume of 739,410 shares, compared to its average volume of 1,154,012. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $130.86. The firm has a market cap of $31.25 billion, a PE ratio of 47.40, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10. The business's 50 day moving average price is $125.52 and its 200-day moving average price is $110.58. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The company had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.05 billion. During the same period in the previous year, the company posted $0.92 earnings per share. Xylem's revenue for the quarter was up 40.6% on a year-over-year basis. Research analysts forecast that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were given a $0.36 dividend. The ex-dividend date was Tuesday, February 20th. This is a boost from Xylem's previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.12%. Xylem's payout ratio is 52.94%.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.